Winton Group’s UroGen Pharma URGN Stock Holding History

Winton Group’s Portfolio URGN Stock Details URGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-13,188	Closed	-$309K	–	1381
2025 Q4	$309K	Buy	+13,188	New	+$286K	0.01%	734
2018 Q4	–	Sell	-4,673	Closed	-$221K	–	1043
2018 Q3	$221K	Buy	+4,673	New	+$217K	﹤0.01%	938

Other funds holding URGN

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $86.4B AUM 59.51% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

KCM

Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return

JFG

Jefferies Financial Group New York $15.2B AUM 55.75% 1-Year Est. Return

PBA

Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

ACA

Acorn Capital Advisors New York $366M AUM 474.6% 1-Year Est. Return

SG Americas Securities New York $179B AUM 65.34% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Winton Group's URGN Position: Q1 2026 in Review

Winton Group sold out of UroGen Pharma (URGN) in Q1 2026, closing a stake of 13,188 shares — an estimated $309K sold.

Winton Group first reported a position in URGN in Q3 2018 and held it in 2 quarters. The position peaked at $309K in Q4 2025. 173 funds tracked by Wall St. Rank hold URGN as of Q1 2026.

Winton Group reported no remaining UroGen Pharma position as of Q1 2026 after selling out during the quarter.
Winton Group sold 13,188 UroGen Pharma shares in Q1 2026, an estimated $309K.
Winton Group first reported a position in UroGen Pharma in Q3 2018 and held it in 2 quarters.
Winton Group's UroGen Pharma position peaked at $309K in Q4 2025.
173 funds tracked by Wall St. Rank held UroGen Pharma as of Q1 2026.

Based on Winton Group's 13F filing for Q1 2026, filed 12 May 2026.